{ "docId": "019dd923-5ca1-7489-b639-45501f4b359b", "docSlug": "158df8627a0b9aca", "documentTitle": "Opioid Conflicts Majority Staff Report", "authorId": "McKinsey", "authorName": "U.S. House Committee on Oversight and Reform", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 47, "pageCount": 53, "prevPage": 46, "nextPage": 48, "slideType": "appendix_disclosure", "function": "cite_precedent", "density": "overcrowded", "nDataPoints": 0, "notes": "This appears to be a page from a formal investigative report or legal document, given the footnote style and content.", "elementsJson": [ "paragraph", "screenshot", "footnote" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/47", "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b", "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json", "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-47", "components": [ { "bbox": null, "kind": "callout", "text": "We'd love to arrange a meeting with the head of our healthcare practice to share perspectives and learn your personal priorities.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd951-cdec-74db-b49e-11e0a9187f2c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.335, "w": 0.634, "x": 0.183, "y": 0.362 }, "kind": "other", "text": "Begin forwarded message: From: \"Alex Azar\" [Redacted] Date: January 27, 2018 at 10:37:35 PM EST To: martin_elling@mckinsey.com Cc: dan_tinkoff@mckinsey.com Subject: [EXT]Re: One giant step! Congratulations Thanks guys. Very grateful for all your help. Let me get my sea legs over there and we can chat about the practice and connection to HHS. Best, Alex Work email will be: alex.azar@hhs.gov On Jan 25, 2018, at 9:17 AM, martin_elling@mckinsey.com wrote: Alex- I am just landing from Asia and saw the news. I am so very excited for you at your confirmation to Secretary of HHS. This is a monumental personal achievement that will allow you a platform to help improve the health of all Americans and influence trends that will help billions of people beyond our shores. From your testimony it is clear you have ambitious goals for the role which is exciting. We’d love to arrange a meeting with the head of our healthcare practice to share perspectives and learn your personal priorities. Let us know if that is helpful. Again, congratulations on this tremendous step onto a platform of profound influence on everyday people’s lives.", "attrs": null, "subkind": "unclassified", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "186b4700-6471-4b49-9db1-cb207770c0a3", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.045, "w": 0.77, "x": 0.118, "y": 0.116 }, "kind": "paragraph", "text": "distributors, will have an important role to play.225 The section of the transition memo originally titled “Addressing drug prices” was renamed “Ensuring the value of pharmaceuticals.”226", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "011526ea-c83d-4756-a27f-95c1e09ac7fc", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.045, "w": 0.77, "x": 0.118, "y": 0.704 }, "kind": "paragraph", "text": "Other McKinsey consultants enjoyed a close relationship with HHS during Secretary Azar’s tenure, even those who may have potentially advised Purdue. In 2014, McKinsey stated in a presentation to Purdue that it would “bring to bear” the expertise of select McKinsey", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "6a5e36ab-b96d-4f16-8b33-dc8d8e2837d9", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.032, "w": 0.77, "x": 0.118, "y": 0.184 }, "kind": "paragraph", "text": "The Committee has obtained evidence that the McKinsey memo was sent to Secretary Azar, but has not confirmed precisely when the transition memo was sent.227", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "95f09aed-0387-404c-a8f2-2900608bf628", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.085, "w": 0.77, "x": 0.118, "y": 0.237 }, "kind": "paragraph", "text": "On January 25, 2018, one day after Secretary Azar’s confirmation, McKinsey Senior Partner Martin Elling, whom Secretary Azar had earlier emailed seeking job advice, and another McKinsey partner emailed Secretary Azar to offer their congratulations. Mr. Elling wrote: “We’d love to arrange a meeting with the head of our healthcare practice to share perspectives and learn your personal priorities.” On January 27, 2018, Secretary Azar responded: “Thanks guys. Very grateful for all your help.”228", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "fc3991c3-c48b-488e-940f-4e9bdc18f900", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "Thanks guys. Very grateful for all your help. Let me get my sea legs over there and we can chat about the practice and connection to HHS. — Alex Azar", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd951-cdec-74db-b49e-14eb05cca85e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.115, "w": 0.77, "x": 0.118, "y": 0.775 }, "kind": "source-note", "text": "225 MCK-HCOR-0085425, Page 5. 226 Id., Page 6. 227 MCK-HCOR-0173887. A senior McKinsey partner wrote to Mr. Elling about Azar: “BTW, here is the transition memo we wrote for him. I had emailed this to him last week but may be helpful for him to receive from you as well.” Mr. Elling replied: “Ok. I can send to him mentioning your reach out. So he knows we are coordinating.” 228 MCK-HCOR-0173887, Page 2.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "1a77eeb6-1955-4251-8c0b-f159de98d271", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 53, "from": 29, "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "loops": [ { "to": 53, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033", "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.", "position": 0, "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }